FDA — authorised 10 May 1995
- Marketing authorisation holder: BAYER HLTHCARE
- Status: approved
FDA authorised Ultravist 370 on 10 May 1995
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 10 May 1995.
BAYER HLTHCARE holds the US marketing authorisation.